• Nuvo Announces Results from European Ankle Sprain Study with Pennsaid 2% americanpharmaceuticalreview
    May 16, 2017
    Nuvo Pharmaceuticals reported topline results from its multi-center, randomized, placebo-controlled, double-blind, parallel group trial in patients, with grade I or II ankle sprains and in particular reported that the Trial had failed to meet its primary
PharmaSources Customer Service